EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

BCL11A Expression in Breast Cancer

Ewa Kątnik, Agnieszka Gomułkiewicz iD, Aleksandra Piotrowska iD, Jędrzej Grzegrzółka, Agnieszka Rusak iD, Alicja Kmiecik, Katarzyna Ratajczak-Wielgomas iD, Piotr Dzięgiel

Current Issues in Molecular Biology · 23.03.2023 · 45 (4) · 2681-2698

DOI: 10.3390/cimb45040175 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Current Issues in Molecular Biology, online erschienen am 23.03.2023. Verfasst von Ewa Kątnik und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Histology and Embryology, Department of Human Morphology and Embryology, Wroclaw Medical University, 50-368 Wroclaw, Poland. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

B-cell leukemia/lymphoma 11A (BCL11A) is a transcription factor that regulates the expression of genes involved in cell division or apoptosis. A link between high BCL11A expression and a worse prognosis has been demonstrated in patients with various cancers. The aim of this study was to investigate the expression pattern of BCL11A in breast cancer (BC) cases and mastopathy samples and to correlate the results with the clinicopathological data. The expression of the BCL11A protein was investigated using immunohistochemistry (IHC) on 200 cases of BC and 13 mastopathy samples. The level of BCL11A mRNA was determined using real-time PCR in 22 cases of BC and 6 mastopathy samples. The expression of BCL11A was also examined at the protein and mRNA levels in BC cell lines. A higher expression level of BCL11A in BC cases was shown compared to mastopathy samples. The expression level of BCL11A in BC cases and in the studied cell lines decreased with the increasing grade of histological malignancy (G). It was also negatively correlated with the primary tumor size. A significantly lower expression of BCL11A was found in BC that did not express estrogen or progesterone receptors and in triple-negative cases. The results of our research suggest that BCL11A may be relevant in the development of BC.

Schlagwörter

Stichwörter der Autor:innen

BCBCL11ATNbreast cancercancer celltriple-negative breast cancer

Autor:innen und Institutionen

  • Division of Histology and Embryology, Department of Human Morphology and Embryology, Wroclaw Medical University, 50-368 Wroclaw, Poland.

ORCID-Profile: Agnieszka Gomułkiewicz, Aleksandra Piotrowska, Agnieszka Rusak, Katarzyna Ratajczak-Wielgomas

Zitieren

APA

Kątnik, E., Gomułkiewicz, A., Piotrowska, A., Grzegrzółka, J., Rusak, A., Kmiecik, A., Ratajczak-Wielgomas, K., & Dzięgiel, P. (2023). BCL11A Expression in Breast Cancer. Current Issues in Molecular Biology, 45(4), 2681-2698. https://doi.org/10.3390/cimb45040175

Vancouver

Kątnik E, Gomułkiewicz A, Piotrowska A, Grzegrzółka J, Rusak A, Kmiecik A, et al. BCL11A Expression in Breast Cancer. Current Issues in Molecular Biology. 2023;45(4):2681-2698. doi:10.3390/cimb45040175

BibTeX
@article{Ktnik2023,
  author = {Kątnik, Ewa and Gomułkiewicz, Agnieszka and Piotrowska, Aleksandra and Grzegrzółka, Jędrzej and Rusak, Agnieszka and Kmiecik, Alicja and Ratajczak-Wielgomas, Katarzyna and Dzięgiel, Piotr},
  title = {BCL11A Expression in Breast Cancer},
  journal = {Current Issues in Molecular Biology},
  year = {2023},
  volume = {45},
  number = {4},
  pages = {2681--2698},
  doi = {10.3390/cimb45040175}
}
Kostenlos starten →